We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Viking Therapeutics Inc | NASDAQ:VKTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -0.03% | 78.19 | 78.15 | 78.25 | 81.86 | 76.51 | 78.27 | 2,905,515 | 19:41:26 |
FORM 3
| Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Mancini Marianna |
2. Date of Event Requiring Statement (MM/DD/YYYY)
| 3. Issuer Name and Ticker or Trading Symbol Viking Therapeutics, Inc. [VKTX] |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Operating Officer / | ||
5. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned | |||
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock, par value $0.00001 per share | 94655 (1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Buy) | 3/31/2021 (2) | 3/31/2030 | Common Stock | 18000 | $4.68 | D | |
Stock Option (Right to Buy) | 1/3/2021 (3) | 1/3/2030 | Common Stock | 54000 | $7.77 | D | |
Stock Option (Right to Buy) | 10/31/2020 (4) | 10/31/2029 | Common Stock | 4000 | $6.47 | D | |
Stock Option (Right to Buy) | 7/31/2020 (5) | 7/31/2029 | Common Stock | 10000 | $7.69 | D | |
Stock Option (Right to Buy) | 1/15/2020 (6) | 1/15/2029 | Common Stock | 23100 | $8.52 | D | |
Stock Option (Right to Buy) | 8/31/2018 (7) | 8/31/2028 | Common Stock | 12500 | $13.07 | D | |
Stock Option (Right to Buy) | 3/30/2019 (8) | 3/30/2028 | Common Stock | 30000 | $4.37 | D | |
Stock Option (Right to Buy) | 1/19/2019 (9) | 1/19/2028 | Common Stock | 24500 | $4.65 | D | |
Stock Option (Right to Buy) | 8/31/2018 (10) | 8/31/2027 | Common Stock | 10000 | $1.04 | D | |
Stock Option (Right to Buy) | 6/30/2018 (11) | 6/30/2027 | Common Stock | 15000 | $1.08 | D | |
Stock Option (Right to Buy) | 1/5/2017 (12) | 1/5/2027 | Common Stock | 23054 | $1.23 | D | |
Stock Option (Right to Buy) | 1/5/2018 (13) | 1/5/2027 | Common Stock | 30000 | $1.23 | D | |
Stock Option (Right to Buy) | 6/30/2017 (14) | 6/30/2026 | Common Stock | 15000 | $1.26 | D | |
Stock Option (Right to Buy) | 3/14/2016 (15) | 3/14/2026 | Common Stock | 4873 | $1.88 | D | |
Stock Option (Right to Buy) | 3/4/2017 (16) | 3/4/2026 | Common Stock | 15000 | $2.15 | D | |
Stock Option (Right to Buy) | 5/21/2016 (17) | 5/21/2025 | Common Stock | 15000 | $9.13 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Mancini Marianna C/O VIKING THERAPEUTICS, INC. 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO, CA 92130 | Chief Operating Officer |
Signatures | ||
/s/ Michael Morneau, as Attorney-in-Fact | 1/6/2021 | |
**Signature of Reporting Person | Date |
1 Year Viking Therapeutics Chart |
1 Month Viking Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions